Endotoxaemia induces resistance to activated protein C in healthy humans
Open Access
- 16 June 2006
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 134 (2), 213-219
- https://doi.org/10.1111/j.1365-2141.2006.06127.x
Abstract
Systemic inflammation activates the tissue factor/factor VIIa complex (TF/FVIIa), leading to a procoagulant state, which may be enhanced by impairment of physiological anticoagulant pathways, such as the protein C system. Besides impaired protein C activation, resistance to activated protein C (APC) may occur. We studied the effect of endotoxemia on APC resistance, analysed its determinants and evaluated the effect of TF/FVIIa inhibition on endotoxin‐induced APC resistance. Sixteen healthy male volunteers participated in the study, eight receiving endotoxin alone and eight receiving the combination of endotoxin and recombinant Nematode Anticoagulant Protein c2 (rNAPc2), a potent inhibitor of TF/FVIIa. Parameters of coagulation were subsequently studied. The sensitivity to APC was determined by two tests: a test based on the endogenous thrombin potential and a test based on the activated partial thromboplastin time. In response to endotoxemia, both tests detected a transient APC resistance that was predominantly mediated by an increase in factor VIII and was not influenced by TF/FVIIa inhibition. In vitro tests confirmed that an increase in factor VIII induced APC resistance, as measured by both tests. This finding suggests that APC resistance might play a role in the procoagulant state occurring during human endotoxemia.This publication has 32 references indexed in Scilit:
- Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutationJournal of Thrombosis and Haemostasis, 2005
- Crosstalk between inflammation and thrombosisMaturitas, 2004
- Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemiaBlood, 2003
- The Protein C PathwaySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2003
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- The protein C pathwayCritical Care Medicine, 2000
- Acquired APC resistance and oral contraceptives: differences between two functional testsBritish Journal of Haematology, 1999
- Raised factor VIII is associated with coronary thrombotic eventsHeart, 1998
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences of the United States of America, 1993
- The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992